Business Standard

Govt exploring options on financing Covid vaccine development: Health secy

Union Health Minister Harsh Vardhan had on October 4 said that the Centre estimates to receive and utilise 40-50 crore doses of Covid-19 vaccine covering 20-25 crore people by July next year

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
Premium

The first option that is being explored is advanced market commitments by different countries and the second one is providing financial help to vaccine manufacturers in terms of conducting their research and development.

Press Trust of India New Delhi
Advanced market commitments or providing financial help to firms for conducting research and development and clinical trials of Covid-19 vaccine are options that are under active consideration, the Centre said on Tuesday while reiterating that sufficient financial resources are available to procure 400-500 million doses of vaccine as and when it becomes available.

At a press conference on Tuesday, Union Health Secretary Rajesh Bhushan said that a subgroup under the National Expert Committee on Vaccine Administration for Covid-19 has already mapped the existing cold chain presently being utilised under the government's immunisation programme and has also made a projection of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in